Assenagon Asset Management
VIVO

Assenagon Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Assenagon Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-280,426
Closed -$8.84M – 1499
2022
Q3 		$8.84M Buy
280,426
+100,256
+56% +$3.25M 0.03% 370
2022
Q2 		$5.48M Buy
180,170
+52,963
+42% +$1.43M 0.02% 514
2022
Q1 		$3.3M Sell
127,207
-92,449
-42% -$2.2M 0.01% 664
2021
Q4 		$4.48M Buy
+219,656
New +$4.21M 0.01% 552
2020
Q2 		– Sell
-606,621
Closed -$5.1M – 1276
2020
Q1 		$5.1M Buy
606,621
+92,964
+18% +$783K 0.04% 225
2019
Q4 		$5.02M Buy
513,657
+172,857
+51% +$1.62M 0.03% 241
2019
Q3 		$3.23M Sell
340,800
-371,789
-52% -$3.92M 0.02% 311
2019
Q2 		$8.47M Buy
+712,589
New +$8.58M 0.06% 184
2019
Q1 		– Sell
-64,472
Closed -$1.12M – 1163
2018
Q4 		$1.12M Sell
64,472
-224,198
-78% -$3.82M 0.01% 619
2018
Q3 		$4.3M Buy
+288,670
New +$4.48M 0.04% 334
2018
Q1 		– Sell
-268,889
Closed -$3.76M – 791
2017
Q4 		$3.76M Buy
+268,889
New +$3.94M 0.04% 317

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management's VIVO Position: Q4 2022 in Review

Assenagon Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 280,426 shares — an estimated $8.84M sold.

Assenagon Asset Management first reported a position in VIVO in Q4 2017 and held it in 11 quarters. The position peaked at $8.84M in Q3 2022. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Assenagon Asset Management reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 280,426 Meridian Bioscience Inc shares in Q4 2022, an estimated $8.84M.
  • Assenagon Asset Management first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 11 quarters.
  • Assenagon Asset Management's Meridian Bioscience Inc position peaked at $8.84M in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.